Skip to content
Randy Garutti became the CEO of Shake Shack Inc. (NYSE:SHAK) in 2012. This report will, first, examine the CEO......
Microsoft Corp on Tuesday rolled out an important security fix after the U.S. National Security Agency tipped off the company to a serious flaw in its widely used Windows operating system, officials said. Microsoft said the flaw could allow a hacker to forge digital certificates used by some versions of Windows to authenticate and secure data. The NSA and Microsoft said they had not seen any evidence that the flaw had previously been abused, but both urged Windows users to deploy the update as soon as possible....
Today we'll take a closer look at The Charles Schwab Corporation (NYSE:SCHW) from a dividend investor's perspective......
In a single day, the talk on the Street has zeroed in on one stock, oncology-focused cell therapy company Adaptimmune Therapeutics (ADAP). Following its presentation of promising data at the 38th annual J.P. Morgan Healthcare Conference, shares took off, posting a whopping 200% one-day gain.The data revealed that its MAGE-A4 (ADP-A2M4 and next-generation ADP-A2M4CD8) and AFP (ADP-A2AFP) therapies, part of its SPEAR T-cell platform, demonstrated initial solid tumor responses in four indications: gastro-esophageal junction, head and neck, liver cancers and melanoma.“These responses demonstrate that our proprietary SPEAR T-cell platform is clearly active and can overcome the challenges of treating a range of solid tumors with a T-cell therapy product,” CEO Adrian Rawcliffe commented.While only two of the responses were confirmed, the implications are significant. The efficacy of SPEAR T-cells in sarcoma has already been demonstrated, but some have been skeptical of the TCR/cell therapy approach in treating other forms of cancer...
FICO scores tend to increase with age....
Pharmaceutical products manufacturer Lannett Company, Inc. (NYSE: LCI) said Monday that its New Drug Application for cocaine hydrochloride nasal solution under the brand name Numbrino has received FDA approval. "The FDA's approval of our Cocaine HCl product, the first NDA approval to include full clinical trials in the company's history, marks a major milestone in Lannett's 70+ years of operations," CEO Tim Crew said in a statement. Numbrino nasal solution is an ester local anesthetic indicated for the introduction of local anesthesia of the mucous membranes for conducting surgeries or diagnostic operations through the nasal cavities of adults....
